SMTL ID : 7quw.1

CVB3-3Cpro in complex with inhibitor MG-78

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

monomer

Ligands

1 x I70: (1R,2S,5S)-N-{(2S,3R)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide(Covalent)

I70.1: 17 residues within 4Å: Chain A: F.25, R.39, H.40, L.125, N.126, L.127, G.128, T.142, R.143, A.144, G.145, Q.146, C.147, H.161, V.162, G.163, G.164 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:H.40, A:L.125, A:L.127 Hydrogen bonds: A:G.128, A:T.142, A:G.145, A:Q.146, A:C.147, A:V.162, A:G.164, A:G.164

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gohl, M. et al., From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease. Molecules (2022)

Release Date

2022-03-09

Peptides

Protease 3C: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Protease 3C